Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synovis Surgical Innovations, a subsidiary of Baxter International, is a medical device company focused on developing and manufacturing products for soft tissue repair and regenerative medicine. Originally a division of Synovis Life Technologies, the company was acquired by Baxter in 2012 to bolster its biosurgery and regenerative medicine portfolio. Its core product line includes implantable biomaterials such as the Veritas Collagen Matrix and Peri-Strips Dry, which are used for surgical staple line reinforcement in bariatric and general surgery. Additionally, the company provides specialized solutions for vascular patching and dural repair, as well as microsurgical instruments through its Micro Companies Alliance. Synovis is headquartered in St. Paul, Minnesota, and its technologies are utilized globally by surgeons in reconstructive, vascular, and neurosurgical specialties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synovis Surgical Innovations.